These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35094186)

  • 1. Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers.
    Mathew AT; Jain B; Dee EC; Johnson J; Chino F
    Ann Surg Oncol; 2022 Jun; 29(6):3381-3383. PubMed ID: 35094186
    [No Abstract]   [Full Text] [Related]  

  • 2. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Sankaran R; O'Connor J; Nuliyalu U; Diaz A; Nathan H
    Ann Surg Oncol; 2024 Jul; 31(7):4339-4348. PubMed ID: 38506934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers.
    Kasthuri VS; Alsoof D; Balmaceno-Criss M; Daher M; McDonald CL; Diebo BG; Kuris EO; Daniels AH
    Spine J; 2024 Feb; 24(2):304-309. PubMed ID: 38440969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.
    In H; Neville BA; Lipsitz SR; Corso KA; Weeks JC; Greenberg CC
    Ann Surg; 2012 May; 255(5):890-5. PubMed ID: 22504278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition Education Services Described on National Cancer Institute (NCI)-Designated Cancer Center Websites.
    Polak R; Reilly JM; Elson LE; Gallegos-Kearin VC; Bhatnagar S; Schneider JC; Silver JK
    J Cancer Educ; 2019 Oct; 34(5):860-864. PubMed ID: 29978360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of NCI-designated cancer centers finds most are out-of-network on exchanges.
    Schatz A; Winckworth Prejsnar K
    Am J Manag Care; 2018 Oct; 24(12 Spec No.):SP517-SP518. PubMed ID: 30550251
    [No Abstract]   [Full Text] [Related]  

  • 7. Higher Prices for Cancer Surgery at National Cancer Institute-Designated Cancer Centers-Are Payers Achieving Value for Their Dollars?
    Keating NL
    JAMA Netw Open; 2021 Aug; 4(8):e2119716. PubMed ID: 34342654
    [No Abstract]   [Full Text] [Related]  

  • 8. State of Integration of Palliative Care at National Cancer Institute-Designated and Nondesignated Cancer Centers.
    Hui D; De La Rosa A; Bruera E
    JAMA Oncol; 2020 Aug; 6(8):1292-1295. PubMed ID: 32614444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A National Survey of Palliative Care Team Compositions.
    Chen J; de la Rosa A; Lai D; De La Cruz M; Zhukovsky D; Revere L; Lairson D; Wermuth P; Hui D
    J Palliat Care; 2022 Apr; 37(2):142-151. PubMed ID: 34939878
    [No Abstract]   [Full Text] [Related]  

  • 10. Population-based geographic access to parent and satellite National Cancer Institute Cancer Center Facilities.
    Onega T; Alford-Teaster J; Wang F
    Cancer; 2017 Sep; 123(17):3305-3311. PubMed ID: 28464212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Parking Fees at National Cancer Institute-Designated Cancer Treatment Centers.
    Lee A; Shah K; Chino F
    JAMA Oncol; 2020 Aug; 6(8):1295-1297. PubMed ID: 32672809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance With Price Transparency Rules at US National Cancer Institute-Designated Cancer Centers.
    Chino F; Johnson J; Moss H
    JAMA Oncol; 2021 Dec; 7(12):1903-1904. PubMed ID: 34709359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Masking Policies at National Cancer Institute-Designated Cancer Centers During Winter 2023 to 2024 COVID-19 Surge.
    Hoerger M; Rivera D; Mossman B; Sherard B; Peyser T; Alcorn TM
    JAMA Netw Open; 2024 Jul; 7(7):e2424999. PubMed ID: 39083276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation Between Narrow Networks and Providers of Cancer Care.
    Yasaitis L; Bekelman JE; Polsky D
    J Clin Oncol; 2017 Sep; 35(27):3131-3135. PubMed ID: 28678667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of NCI Cancer Center attendance in Medicare patients with lung, breast, colorectal, or prostate cancer.
    Onega T; Duell EJ; Shi X; Demidenko E; Goodman D
    J Gen Intern Med; 2009 Feb; 24(2):205-10. PubMed ID: 19067086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catchment Areas and Community Outreach and Engagement: The New Mandate for NCI-Designated Cancer Centers.
    Paskett ED; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):517-519. PubMed ID: 29716925
    [No Abstract]   [Full Text] [Related]  

  • 17. Delivery of Financial Navigation Services Within National Cancer Institute-Designated Cancer Centers.
    de Moor JS; Mollica M; Sampson A; Adjei B; Weaver SJ; Geiger AM; Kramer BS; Grenen E; Miscally M; Ciolino HP
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34222790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence of Dissemination and Implementation Research and Training Grants at National Cancer Institute-Designated Cancer Centers.
    Mueller NM; Hsieh A; Ramanadhan S; Lee RM; Emmons KM
    JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35005429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.
    Xiao R; Ross JS; Gross CP; Dusetzina SB; McWilliams JM; Sethi RKV; Rathi VK
    JAMA Intern Med; 2022 Jun; 182(6):603-611. PubMed ID: 35435948
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.